Affinity DataKi: 1.40nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 22nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 23nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 26nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 38nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 44nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 50nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 70nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 73nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 78nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 85nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 87nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 103nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 107nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 171nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 228nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 246nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 275nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 365nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 410nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 498nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 833nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 927nMAssay Description:Inhibition of human recombinant IDE-mediated fluorescein-Abeta-(1-40)-Lys-biotin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 1.15E+3nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 1.28E+3nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 1.89E+3nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 3.26E+3nMAssay Description:Inhibition of human recombinant IDE-mediated insulin degradationMore data for this Ligand-Target Pair
Affinity DataKi: 5.28E+3nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 7.02E+3nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 7.75E+3nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: 1.80E+4nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: >3.30E+4nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: >3.30E+4nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: >3.30E+4nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataKi: >3.30E+4nMAssay Description:Inhibition of human recombinant IDE-mediated FRET1 degradationMore data for this Ligand-Target Pair
Affinity DataIC50: 1.15E+3nMAssay Description:Inhibition of MMP7 (unknown origin)-mediated omniMMP degradationMore data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 371nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 549nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 405nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 164nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 63nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 2.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 2.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 5.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 5.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 5.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 5.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 5.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair
TargetE3 ubiquitin-protein ligase parkin(Human)
Mayo Foundation For Medical Education and Research
US Patent
Mayo Foundation For Medical Education and Research
US Patent
Affinity DataEC50: 5.00E+3nMAssay Description:Ub-charging of E2 enzyme was performed for 90 min at 30° C. in a reaction containing 0.1 μM GST-E1, 3.3 μM E2/UbcH7, 10 μM FLAG-Ub and...More data for this Ligand-Target Pair